Global Canine Cancer Screening Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI10249334

Publication Date:

October 14, 2024

Pages:

115

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

Canine cancer screening is a process used to detect cancer in dogs at an early stage, often before symptoms become noticeable. Early detection can significantly improve the chances of successful treatment. Screening methods may include blood tests, imaging (such as X-rays or ultrasounds), and physical exams. Recently, there has also been progress in genetic testing and liquid biopsy techniques, which involve detecting cancer-related DNA or biomarkers in a dog's blood sample.
The global Canine Cancer Screening market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (publisher)' newest research report, the 鈥淐anine Cancer Screening Industry Forecast鈥� looks at past sales and reviews total world Canine Cancer Screening sales in 2022, providing a comprehensive analysis by region and market sector of projected Canine Cancer Screening sales for 2023 through 2029. With Canine Cancer Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Canine Cancer Screening industry.
This Insight Report provides a comprehensive analysis of the global Canine Cancer Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Canine Cancer Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Canine Cancer Screening market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Canine Cancer Screening and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Canine Cancer Screening.
United States market for Canine Cancer Screening is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Canine Cancer Screening is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Canine Cancer Screening is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Canine Cancer Screening players cover IDEXX, Mars Pedtcare, Zoetis, PetDx, Molecular Diagnostics (MDxHealth), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Canine Cancer Screening market by product type, application, key players and key regions and countries.
Segmentation by Type:
Liquid Biopsy (Blood-Based Tests)
Tissue Biopsy
Genomic Testing
Biomarker Tests
Segmentation by Application:
Veterinary Clinics
Veterinary Hospitals
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Liquid Biopsy (Blood-Based Tests)
Tissue Biopsy
Genomic Testing
Biomarker Tests
Segmentation by Application:
Veterinary Clinics
Veterinary Hospitals
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
IDEXX
Mars Pedtcare
Zoetis
PetDx
Molecular Diagnostics (MDxHealth)
Biom茅rieux SA
OncoK9
Antech Diagnostics
VolitionRx Limited
Oncotect
Heska Corporation

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Canine Cancer Screening Market Size 2019-2030
2.1.2 Canine Cancer Screening Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Canine Cancer Screening by Country/Region, 2019, 2023 & 2030
2.2 Canine Cancer Screening Segment by Type
2.2.1 Liquid Biopsy (Blood-Based Tests)
2.2.2 Tissue Biopsy
2.2.3 Genomic Testing
2.2.4 Biomarker Tests
2.3 Canine Cancer Screening Market Size by Type
2.3.1 Canine Cancer Screening Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Canine Cancer Screening Market Size Market Share by Type (2019-2024)
2.4 Canine Cancer Screening Segment by Application
2.4.1 Veterinary Clinics
2.4.2 Veterinary Hospitals
2.4.3 Other
2.5 Canine Cancer Screening Market Size by Application
2.5.1 Canine Cancer Screening Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Canine Cancer Screening Market Size Market Share by Application (2019-2024)
3 Canine Cancer Screening Market Size by Player
3.1 Canine Cancer Screening Market Size Market Share by Player
3.1.1 Global Canine Cancer Screening Revenue by Player (2019-2024)
3.1.2 Global Canine Cancer Screening Revenue Market Share by Player (2019-2024)
3.2 Global Canine Cancer Screening Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Canine Cancer Screening by Region
4.1 Canine Cancer Screening Market Size by Region (2019-2024)
4.2 Global Canine Cancer Screening Annual Revenue by Country/Region (2019-2024)
4.3 Americas Canine Cancer Screening Market Size Growth (2019-2024)
4.4 APAC Canine Cancer Screening Market Size Growth (2019-2024)
4.5 Europe Canine Cancer Screening Market Size Growth (2019-2024)
4.6 Middle East & Africa Canine Cancer Screening Market Size Growth (2019-2024)
5 Americas
5.1 Americas Canine Cancer Screening Market Size by Country (2019-2024)
5.2 Americas Canine Cancer Screening Market Size by Type (2019-2024)
5.3 Americas Canine Cancer Screening Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Canine Cancer Screening Market Size by Region (2019-2024)
6.2 APAC Canine Cancer Screening Market Size by Type (2019-2024)
6.3 APAC Canine Cancer Screening Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Canine Cancer Screening Market Size by Country (2019-2024)
7.2 Europe Canine Cancer Screening Market Size by Type (2019-2024)
7.3 Europe Canine Cancer Screening Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Canine Cancer Screening by Region (2019-2024)
8.2 Middle East & Africa Canine Cancer Screening Market Size by Type (2019-2024)
8.3 Middle East & Africa Canine Cancer Screening Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Canine Cancer Screening Market Forecast
10.1 Global Canine Cancer Screening Forecast by Region (2025-2030)
10.1.1 Global Canine Cancer Screening Forecast by Region (2025-2030)
10.1.2 Americas Canine Cancer Screening Forecast
10.1.3 APAC Canine Cancer Screening Forecast
10.1.4 Europe Canine Cancer Screening Forecast
10.1.5 Middle East & Africa Canine Cancer Screening Forecast
10.2 Americas Canine Cancer Screening Forecast by Country (2025-2030)
10.2.1 United States Market Canine Cancer Screening Forecast
10.2.2 Canada Market Canine Cancer Screening Forecast
10.2.3 Mexico Market Canine Cancer Screening Forecast
10.2.4 Brazil Market Canine Cancer Screening Forecast
10.3 APAC Canine Cancer Screening Forecast by Region (2025-2030)
10.3.1 China Canine Cancer Screening Market Forecast
10.3.2 Japan Market Canine Cancer Screening Forecast
10.3.3 Korea Market Canine Cancer Screening Forecast
10.3.4 Southeast Asia Market Canine Cancer Screening Forecast
10.3.5 India Market Canine Cancer Screening Forecast
10.3.6 Australia Market Canine Cancer Screening Forecast
10.4 Europe Canine Cancer Screening Forecast by Country (2025-2030)
10.4.1 Germany Market Canine Cancer Screening Forecast
10.4.2 France Market Canine Cancer Screening Forecast
10.4.3 UK Market Canine Cancer Screening Forecast
10.4.4 Italy Market Canine Cancer Screening Forecast
10.4.5 Russia Market Canine Cancer Screening Forecast
10.5 Middle East & Africa Canine Cancer Screening Forecast by Region (2025-2030)
10.5.1 Egypt Market Canine Cancer Screening Forecast
10.5.2 South Africa Market Canine Cancer Screening Forecast
10.5.3 Israel Market Canine Cancer Screening Forecast
10.5.4 Turkey Market Canine Cancer Screening Forecast
10.6 Global Canine Cancer Screening Forecast by Type (2025-2030)
10.7 Global Canine Cancer Screening Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Canine Cancer Screening Forecast
11 Key Players Analysis
11.1 IDEXX
11.1.1 IDEXX Company Information
11.1.2 IDEXX Canine Cancer Screening Product Offered
11.1.3 IDEXX Canine Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 IDEXX Main Business Overview
11.1.5 IDEXX Latest Developments
11.2 Mars Pedtcare
11.2.1 Mars Pedtcare Company Information
11.2.2 Mars Pedtcare Canine Cancer Screening Product Offered
11.2.3 Mars Pedtcare Canine Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Mars Pedtcare Main Business Overview
11.2.5 Mars Pedtcare Latest Developments
11.3 Zoetis
11.3.1 Zoetis Company Information
11.3.2 Zoetis Canine Cancer Screening Product Offered
11.3.3 Zoetis Canine Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Zoetis Main Business Overview
11.3.5 Zoetis Latest Developments
11.4 PetDx
11.4.1 PetDx Company Information
11.4.2 PetDx Canine Cancer Screening Product Offered
11.4.3 PetDx Canine Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 PetDx Main Business Overview
11.4.5 PetDx Latest Developments
11.5 Molecular Diagnostics (MDxHealth)
11.5.1 Molecular Diagnostics (MDxHealth) Company Information
11.5.2 Molecular Diagnostics (MDxHealth) Canine Cancer Screening Product Offered
11.5.3 Molecular Diagnostics (MDxHealth) Canine Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Molecular Diagnostics (MDxHealth) Main Business Overview
11.5.5 Molecular Diagnostics (MDxHealth) Latest Developments
11.6 Biom茅rieux SA
11.6.1 Biom茅rieux SA Company Information
11.6.2 Biom茅rieux SA Canine Cancer Screening Product Offered
11.6.3 Biom茅rieux SA Canine Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Biom茅rieux SA Main Business Overview
11.6.5 Biom茅rieux SA Latest Developments
11.7 OncoK9
11.7.1 OncoK9 Company Information
11.7.2 OncoK9 Canine Cancer Screening Product Offered
11.7.3 OncoK9 Canine Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 OncoK9 Main Business Overview
11.7.5 OncoK9 Latest Developments
11.8 Antech Diagnostics
11.8.1 Antech Diagnostics Company Information
11.8.2 Antech Diagnostics Canine Cancer Screening Product Offered
11.8.3 Antech Diagnostics Canine Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Antech Diagnostics Main Business Overview
11.8.5 Antech Diagnostics Latest Developments
11.9 VolitionRx Limited
11.9.1 VolitionRx Limited Company Information
11.9.2 VolitionRx Limited Canine Cancer Screening Product Offered
11.9.3 VolitionRx Limited Canine Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 VolitionRx Limited Main Business Overview
11.9.5 VolitionRx Limited Latest Developments
11.10 Oncotect
11.10.1 Oncotect Company Information
11.10.2 Oncotect Canine Cancer Screening Product Offered
11.10.3 Oncotect Canine Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Oncotect Main Business Overview
11.10.5 Oncotect Latest Developments
11.11 Heska Corporation
11.11.1 Heska Corporation Company Information
11.11.2 Heska Corporation Canine Cancer Screening Product Offered
11.11.3 Heska Corporation Canine Cancer Screening Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Heska Corporation Main Business Overview
11.11.5 Heska Corporation Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂